Press Release

Omada Health Reports First Quarter 2026 Results

05/07/2026

Revenue up 42% Year over Year; Total Members Surpass One Million;Expanded Channels Now Include All Three of the Nation’s Leading PBMs

Learn more
Omada Health Reports First Quarter 2026 Results

White Papers

See all

Beyond Stigma and Scripts: What the System Gets Wrong About Obesity Care

05/07/2026

In one of the largest surveys of its kind, Omada polled more than 3,000 people who have used GLP‑1s for weight loss, offering a timely view of how the GLP‑1 experience is evolving and where the.

Optimizing The Quantity and Quality of GLP-1 Weight Loss: Evidence from a 12-Week Comparative Study

04/10/2026

GLP‑1 medications have changed what’s possible for weight loss, but they also raise a critical question: what are people losing—fat, lean mass, or both? Omada’s Insights Lab conducted a 12‑week.

GLP-1s are Changing Americans’ Bodies–But Not in the Way You Think

02/11/2026

Demand for GLP-1 agonists has been steadily climbing. From 2019 to 2023, the number of patients without diabetes who started GLP-1 treatment for obesity rose 700%; and demand for these ‘miracle’.

See all

Webinars & Events

See all

NEBGH Cardiometabolic Health as a Business Imperative

03/16/2026

We’re thrilled to join the NEBGH Cardiometabolic Health as a Business Imperative Conference for the first time. This event brings together senior HR, benefits, and healthcare leaders for a strategic.

HLTH: 2026 Sponsor

02/24/2026

We’re proud to return as a sponsor of HLTH 2026 in Las Vegas. As the premier event for healthcare innovation, HLTH brings together more than 12,000 leaders, executives, and visionaries shaping the.

AHIP: 2026 Bronze Sponsor

02/24/2026

Omada Health is heading to Las Vegas for AHIP 2026, the industry’s flagship conference. This premier event brings together leaders, innovators, and change-makers from across the health insurance.

See all

Keep Browsing

See All Posts
Become an Omada Insider
Sign Up